Cellular factors maintaining and reversing silencing of bacterial chromatin

维持和逆转细菌染色质沉默的细胞因子

基本信息

  • 批准号:
    10583882
  • 负责人:
  • 金额:
    $ 38.83万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2003
  • 资助国家:
    美国
  • 起止时间:
    2003-02-01 至 2027-05-31
  • 项目状态:
    未结题

项目摘要

All living cells possess mechanisms that partition the chromosomal DNA into actively transcribed, accessible domains, and transcriptionally silent domains densely packed by DNA-bound proteins. In Escherichia coli, nucleoid-associated proteins (NAPs) assemble into nucleoprotein filaments that cover several kilobase-long regions of DNA, silencing expression of horizontally acquired xenogenes, virulence factors or enzymes needed for utilization of exotic nutrients. While silencing of promoters, frequently by exclusion of RNA polymerase, is well studied, silencing during RNA chain elongation has only recently come to light. E. coli H-NS and its homolog StpA are NAPs that directly bind to AT-rich DNA and inhibit transcription initiation and elongation. The available data show that the transcription elongation complex is involved in both maintenance and relief of NAP-mediated silencing. Recent data implicate the ω subunit of RNA polymerase in regulation of global DNA topology and transcription of xenogeneic regions. A universally conserved elongation factor, NusG, and termination factor Rho, which are associated with RNA polymerase genome-wide and stop synthesis of RNAs that are not actively translated, cooperate with H-NS to silence xenogenes and other inactive genes. Conversely, we showed that a specialized NusG paralog, RfaH, which is required for expression of xenogeneic operons, excludes NusG and Rho from the transcribing RNA polymerase and counteracts NAP-mediated silencing. We propose to elucidate molecular mechanisms which control the accessibility of bacterial chromatin, focusing on poorly understood regulation during transcription elongation. In Aim 1, we will investigate effects of the ubiquitous ω subunit on RNA polymerase structure and activity. We will identify cellular factors that interact with ω using genetics and proteomics, characterize ω-induced changes in transcription complexes, and investigate ω effects on in vitro RNA synthesis. In Aim 2, we will study regulation of Rho- dependent termination. We posit that hyperactive Rho may be harmful during slow growth or translational stress and will investigate mechanisms by which Rho activity may be globally downregulated, e.g., by changing Rho conformation, promoting the formation of inactive Rho filaments, or blocking Rho binding to RNA. In Aim 3, we will identify new factors that contribute to maintenance of E. coli heterochromatin; determine contributions of different NAPs, Rho, and ω to silencing; and elucidate the molecular mechanism by which RfaH counter-silences NAPs in vitro.
所有活细胞都具有将染色体DNA分割成活跃转录,

项目成果

期刊论文数量(95)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
CBR antimicrobials alter coupling between the bridge helix and the β subunit in RNA polymerase.
  • DOI:
    10.1038/ncomms4408
  • 发表时间:
    2014-03-06
  • 期刊:
  • 影响因子:
    16.6
  • 作者:
    Malinen, Anssi M.;NandyMazumdar, Monali;Turtola, Matti;Malmi, Henri;Grocholski, Thadee;Artsimovitch, Irina;Belogurov, Georgiy A.
  • 通讯作者:
    Belogurov, Georgiy A.
Initial events in bacterial transcription initiation.
  • DOI:
    10.3390/biom5021035
  • 发表时间:
    2015-05-27
  • 期刊:
  • 影响因子:
    5.5
  • 作者:
    Ruff EF;Record MT Jr;Artsimovitch I
  • 通讯作者:
    Artsimovitch I
Termination and antitermination: RNA polymerase runs a stop sign.
Transcriptional pausing in vivo: a nascent RNA hairpin restricts lateral movements of RNA polymerase in both forward and reverse directions.
体内转录暂停:新生的 RNA 发夹限制 RNA 聚合酶向前和反向的横向运动。
  • DOI:
    10.1016/j.jmb.2005.05.052
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Toulme,Francine;Mosrin-Huaman,Christine;Artsimovitch,Irina;Rahmouni,ARachid
  • 通讯作者:
    Rahmouni,ARachid
Mapping the Escherichia coli transcription elongation complex with exonuclease III.
使用核酸外切酶 III 绘制大肠杆菌转录延伸复合物图谱。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

IRINA ARTSIMOVITCH其他文献

IRINA ARTSIMOVITCH的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('IRINA ARTSIMOVITCH', 18)}}的其他基金

Post-initiation control of conjugation by plasmid-encoded H-NS and NusG homologs
通过质粒编码的 H-NS 和 NusG 同源物进行缀合的启动后控制
  • 批准号:
    10301108
  • 财政年份:
    2021
  • 资助金额:
    $ 38.83万
  • 项目类别:
Post-initiation control of conjugation by plasmid-encoded H-NS and NusG homologs
通过质粒编码的 H-NS 和 NusG 同源物进行缀合的启动后控制
  • 批准号:
    10425461
  • 财政年份:
    2021
  • 资助金额:
    $ 38.83万
  • 项目类别:
Mechanism of transcript elongation control by RfaH
RfaH控制转录本延伸的机制
  • 批准号:
    7917089
  • 财政年份:
    2009
  • 资助金额:
    $ 38.83万
  • 项目类别:
Molecular mechanism of antibiotic rifampicin action
抗生素利福平作用的分子机制
  • 批准号:
    6911366
  • 财政年份:
    2005
  • 资助金额:
    $ 38.83万
  • 项目类别:
Molecular mechanism of antibiotic rifampicin action
抗生素利福平作用的分子机制
  • 批准号:
    7052765
  • 财政年份:
    2005
  • 资助金额:
    $ 38.83万
  • 项目类别:
Mechanism of transcript elongation control by RfaH
RfaH控制转录本延伸的机制
  • 批准号:
    8231348
  • 财政年份:
    2003
  • 资助金额:
    $ 38.83万
  • 项目类别:
Mechnanism of transcript elongation control by RfaH
RfaH控制转录本延伸的机制
  • 批准号:
    6696601
  • 财政年份:
    2003
  • 资助金额:
    $ 38.83万
  • 项目类别:
Mechnanism of transcript elongation control by RfaH
RfaH控制转录本延伸的机制
  • 批准号:
    7006102
  • 财政年份:
    2003
  • 资助金额:
    $ 38.83万
  • 项目类别:
Mechanism of transcript elongation control by RfaH
RfaH控制转录本延伸的机制
  • 批准号:
    8788414
  • 财政年份:
    2003
  • 资助金额:
    $ 38.83万
  • 项目类别:
Mechanism of transcript elongation control by RfaH
RfaH控制转录本延伸的机制
  • 批准号:
    10152602
  • 财政年份:
    2003
  • 资助金额:
    $ 38.83万
  • 项目类别:

相似海外基金

DYNBIOTICS - Understanding the dynamics of antibiotics transport in individual bacteria
DYNBIOTICS - 了解抗生素在单个细菌中转运的动态
  • 批准号:
    EP/Y023528/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.83万
  • 项目类别:
    Research Grant
Engineering Streptomyces bacteria for the sustainable manufacture of antibiotics
工程化链霉菌用于抗生素的可持续生产
  • 批准号:
    BB/Y007611/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.83万
  • 项目类别:
    Research Grant
Hitting bacteria with a Bam: Lectin-Like Antimicrobials as New Antibiotics
用 Bam 击中细菌:凝集素类抗菌剂作为新型抗生素
  • 批准号:
    DP230102150
  • 财政年份:
    2023
  • 资助金额:
    $ 38.83万
  • 项目类别:
    Discovery Projects
“L-form” bacteria: basic science, antibiotics, evolution and biotechnology
L 型细菌:基础科学、抗生素、进化和生物技术
  • 批准号:
    FL210100071
  • 财政年份:
    2022
  • 资助金额:
    $ 38.83万
  • 项目类别:
    Australian Laureate Fellowships
Systematic identification of synthetic interactions in bacteria towards the next-generation of antibiotics
系统鉴定细菌与下一代抗生素的合成相互作用
  • 批准号:
    468567
  • 财政年份:
    2022
  • 资助金额:
    $ 38.83万
  • 项目类别:
    Operating Grants
Repurposing Gram-positive Antibiotics for Gram-Negative Bacteria using Antibiotic Adjuvants
使用抗生素佐剂重新利用革兰氏阳性抗生素治疗革兰氏阴性菌
  • 批准号:
    10708102
  • 财政年份:
    2022
  • 资助金额:
    $ 38.83万
  • 项目类别:
Repurposing Gram-positive Antibiotics for Gram-Negative Bacteria using Antibiotic Adjuvants
使用抗生素佐剂重新利用革兰氏阳性抗生素治疗革兰氏阴性菌
  • 批准号:
    10587015
  • 财政年份:
    2022
  • 资助金额:
    $ 38.83万
  • 项目类别:
Isolation, identification and characterization of potentially novel antibiotics from rhizospheric bacteria without detectable in vitro resistance
从根际细菌中分离、鉴定和表征潜在的新型抗生素,且体外未检测到耐药性
  • 批准号:
    10581945
  • 财政年份:
    2021
  • 资助金额:
    $ 38.83万
  • 项目类别:
Developing novel antibiotics from natural products against resistant bacteria
从天然产物中开发针对耐药细菌的新型抗生素
  • 批准号:
    2599490
  • 财政年份:
    2021
  • 资助金额:
    $ 38.83万
  • 项目类别:
    Studentship
Isolation, identification and characterization of potentially novel antibiotics from rhizospheric bacteria without detectable in vitro resistance
从根际细菌中分离、鉴定和表征潜在的新型抗生素,且体外未检测到耐药性
  • 批准号:
    10358855
  • 财政年份:
    2021
  • 资助金额:
    $ 38.83万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了